Post-traumatic stress disorder affects approximately 3.6% of adults in the United States in any given year, and a significant portion of those people do not achieve adequate relief through the treatments they are most commonly offered (Mayo Clinic). Therapy, particularly trauma-focused cognitive behavioral therapy, is a legitimate and effective intervention for many but it has a ceiling, and for patients whose trauma has rewired the brain’s fear circuitry at a deep neurological level, that ceiling can be reached well before symptoms are resolved. At The Mood Center in Annapolis and Columbia, Maryland, we work with patients for whom PTSD has crossed from a psychological challenge into a medical one, and we think it matters to explain clearly why that distinction exists and what it means for treatment.
How PTSD Changes the Brain
Understanding why some PTSD requires medical treatment means understanding what the condition does to the brain. PTSD post-traumatic stress disorder develops after exposure to traumatic events and is characterized by four clusters of symptoms: intrusive re-experiencing (flashbacks, nightmares), avoidance of trauma-related cues, negative changes in thought and mood, and hyperarousal or reactivity (Mayo Clinic). These are not merely emotional responses to a difficult memory. They reflect lasting changes in how the brain processes threat, memory, and safety. Understanding how PTSD relates to other trauma responses is also helpful — for a closer look at the distinctions between early and longer-term reactions, our overview of acute stress disorder vs. PTSD explains how clinicians differentiate the two.
The amygdala a small, almond-shaped structure deep in the brain plays a central role in fear processing and threat detection. Research on fear responses and the amygdala shows that traumatic experiences can sensitize this region, lowering the threshold at which it fires and prolonging the fear response beyond what the situation warrants (PMC). In PTSD, the amygdala behaves as if the trauma is still occurring: it processes neutral stimuli as threats, generates fear responses to reminders that would not affect most people, and resists the regulatory influence of the prefrontal cortex, which under normal circumstances would help calibrate and dampen these responses.
This means that for patients with significant PTSD, the brain is not simply remembering a traumatic event it is physically organized around it in ways that involve structural and functional changes to key neural circuits. Therapy can help patients develop tools to manage these responses and gradually shift their relationship to traumatic memories. But therapy works by engaging the prefrontal cortex, and when that region is itself suppressed by hyperactive stress circuitry, the therapeutic tools can be hard to access. This is the neurological context in which medical treatment becomes not an alternative to therapy, but a biological bridge to it.
When PTSD Becomes Treatment-Resistant
Not all PTSD requires the kind of medical intervention we offer, and we are careful not to suggest otherwise. Many patients do achieve meaningful relief through standard care. Treatment-resistant PTSD where the condition continues to significantly impair daily life despite adequate trials of established treatments is a more specific clinical situation. The clinical markers include persistent significant symptoms after two or more adequate treatment trials, functional impairment that limits work, relationships, or daily activities despite active engagement with treatment, and a pattern of hyperarousal or avoidance that has not meaningfully shifted over time.
For patients in this category, the biological question shifts. If therapy has not produced sufficient change, the obstacle may not be the quality of the therapy. It may be that the neural circuits maintaining the PTSD symptoms are not accessible enough to respond to a cognitive approach alone. That is a medical problem with medical solutions.
The Evidence for Ketamine in PTSD
Clinical research demonstrates that ketamine produces significant and rapid reductions in PTSD symptoms, including the intrusive re-experiencing and hyperarousal that are among the most debilitating features of the condition (PMC). A study published in JAMA Psychiatry found that intravenous ketamine significantly reduced PTSD symptom severity compared to controls, supporting its use as a fast-acting treatment option (JAMA Psychiatry). These are not marginal improvements on symptom scales. They are clinically meaningful reductions in the kinds of symptoms that prevent patients from sleeping, maintaining relationships, or functioning at work.
The mechanism behind this is relevant. Ketamine works through the glutamate system, blocking NMDA receptors and triggering a neuroplastic cascade that may help disrupt the over-consolidated fear memories and the hyperactive amygdala activity that sustain PTSD symptoms. By promoting the formation of new neural connections and the reorganization of existing circuits, ketamine may create a window in which the brain’s fear-memory system becomes less fixed more malleable and more responsive to subsequent therapeutic work. For patients whose PTSD has felt immovable despite sincere effort, this mechanism offers a different kind of hope than simply trying another medication.
Research also shows that repeated ketamine administration produces sustained symptom relief in patients with chronic PTSD, suggesting value beyond a single treatment course (PubMed). Our standard protocol consists of six IV ketamine infusions over three weeks, with booster sessions available on a monthly basis or as needed depending on your response. For patients who respond well to the initial course, these maintenance sessions help extend and preserve the gains that the primary treatment produces. Patients at our Columbia location can find a detailed walkthrough of what to expect in our guide to the ketamine therapy process for PTSD in Columbia, MD.
What IV Ketamine Treatment for PTSD Actually Looks Like at Our Clinic
Each infusion is administered intravenously over 45 minutes in a private treatment room at our Annapolis or Columbia clinic. The room is equipped with a zero-gravity reclining armchair, dimmable lighting, noise-cancelling headphones, and calming music designed to support a calm, contained experience rather than a clinical or sterile one. You are monitored continuously by our trained medical staff throughout every session, and your vitals are observed from start to finish.
During the infusion, some patients experience a dissociative quality a mild sense of detachment from the immediate environment or altered perception of time. This is an expected and temporary effect at the doses we use clinically. It resolves within 15 to 20 minutes of the infusion ending, and patients are advised not to drive on treatment days. We also offer intramuscular ketamine injections IM ketamine as an alternative delivery method for patients for whom IV administration is less appropriate, depending on clinical circumstances.
Ketamine-assisted psychotherapy, or KAP, is available as an adjunct to infusion treatment. Because ketamine promotes neuroplasticity in the hours following a session, the post-infusion window may be a particularly productive time for therapeutic work the brain is more malleable, and new cognitive and emotional patterns may take root more readily. Research supports the integration of psychotherapy with ketamine treatment, suggesting the combination may produce more durable outcomes than ketamine alone (PMC). KAP is available through your own therapist or at an additional charge with a trusted provider at our clinic.
Addressing Two Barriers That Keep PTSD Patients from Seeking Care
Stigma is especially pronounced for PTSD patients, particularly those whose trauma occurred in contexts where asking for help carries its own cultural weight combat veterans, first responders, survivors of assault. We are supporters of the Wounded Warrior Project and the American Foundation for Suicide Prevention, and we understand that the patients who most need care are often the ones with the most reasons to hesitate. Seeking medical treatment for PTSD that has not responded to standard care is not a sign of weakness or of a condition being more severe than manageable. It is a medically appropriate response to a neurological problem.
On the financial side: IV ketamine is self-pay and not currently covered by insurance $425 per session, or $395 per session when purchasing a package of 6, which is our standard initial course. We are in-network with CareFirst, Anthem, Aetna, Cigna, United Healthcare, Tricare, Maryland Medicaid, and Medicare for covered services including TMS and medication management. Patient financing is available for those who need it, and we walk through the full cost picture before you make any decisions. Veterans and active-duty military may have Tricare coverage for other services at our clinic please contact us to discuss your specific situation.
Frequently Asked Questions
How is ketamine different from the medications I’ve already tried for PTSD? Most medications used for PTSD including SSRIs like sertraline and paroxetine, the only two FDA-approved pharmacological treatments for the condition target the serotonin system. Ketamine works through the glutamate system, targeting NMDA receptors and promoting neuroplasticity in circuits involved in fear memory and threat processing. Because it operates through a different biological pathway, patients who have not responded to serotonin-targeted medications may respond differently to ketamine. Results vary by individual.
Do I need a PTSD diagnosis to be considered for ketamine treatment? A thorough clinical evaluation is required before any treatment recommendation at our clinic. We review your full history, current symptoms, prior treatments, and medical background to determine whether IV ketamine is clinically appropriate for your situation. A formal diagnosis of PTSD is relevant context, but the evaluation process is designed to understand your individual clinical picture, not simply confirm a diagnostic label.
Can ketamine help with PTSD even if I’m still in therapy? Yes. Ketamine and psychotherapy are not mutually exclusive many patients pursue both simultaneously, and the neuroplasticity that ketamine promotes may actually enhance the effectiveness of concurrent therapy by making the brain more receptive to the work. Our ketamine-assisted psychotherapy option is specifically designed around this principle. Discuss your current treatment situation with our team and we will help you think through how to integrate approaches appropriately.
What if my PTSD symptoms come back after the initial course? Maintenance booster sessions are available monthly or as needed after the initial six-session protocol. Many patients find that periodic boosters allow them to sustain the gains from the primary course. The frequency and duration of maintenance depends on your individual response to treatment something we assess and discuss with you on an ongoing basis rather than applying a fixed formula.
Key Takeaways
PTSD produces measurable structural and functional changes in the brain, particularly in the amygdala and prefrontal cortex, that explain why some cases do not respond adequately to therapy or standard medication alone.
Clinical research, including a study published in JAMA Psychiatry, demonstrates that IV ketamine produces significant and rapid reductions in PTSD symptom severity, including intrusive re-experiencing and hyperarousal.
Ketamine’s glutamate-based mechanism may help disrupt the over-consolidated fear-memory circuits that sustain PTSD symptoms, creating a neurological window in which therapeutic work becomes more accessible.
Repeated ketamine sessions have been shown to produce sustained relief in patients with chronic PTSD, and our six-infusion protocol with available maintenance boosters is designed to build and preserve that response.
Results vary by individual, and we conduct thorough clinical evaluations before recommending any treatment the goal is to match the right approach to your specific history, not to apply a default protocol.
PTSD that has not responded to standard care is a medical problem, not a personal failure and it has medical solutions worth exploring. We offer free consultations at our Annapolis and Columbia locations, with evening and Saturday appointments available. Call 443-940-MOOD or schedule online to have a direct conversation about whether ketamine therapy for PTSD may be an appropriate next step for your situation.
References
Mayo Clinic. Symptoms of PTSD. https://www.mayoclinic.org/diseases-conditions/post-traumatic-stress-disorder/symptoms-causes/syc-20355967
PMC. Ketamine PTSD efficacy. https://pmc.ncbi.nlm.nih.gov/articles/PMC10316217/
PMC. Fear, stress, and the amygdala. https://pmc.ncbi.nlm.nih.gov/articles/PMC2882379/
JAMA Psychiatry. Efficacy of IV ketamine for PTSD. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1860851
PubMed. Repeated ketamine for chronic PTSD. https://pubmed.ncbi.nlm.nih.gov/33397139/
PMC. Ketamine-assisted psychotherapy. https://pmc.ncbi.nlm.nih.gov/articles/PMC9207256/
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy for PTSD should only be pursued under the supervision of a licensed medical provider familiar with your full medical and psychiatric history. Individual results vary. The treatment descriptions and research findings in this article do not constitute a guarantee of outcomes for any specific patient. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.